Smith+Nephew Unveils AETOS™ Shoulder System at AAOS 2024, Signaling New Era in Shoulder Replacement Technology

Smith+Nephew LSE:SN, NYSE:SNN, a renowned player in the global medical technology landscape, shared exciting news from the floor of the AAOS 2024 Annual Meeting - the full commercial release of the AETOS Shoulder System in the United States marketplace. This advanced shoulder replacement solution integrates seamlessly with ATLASPLAN◊ 3D Planning Software and utilizes Patient Specific Instrumentation. The company proudly announced the receipt of 510(k) clearance, signifying a major milestone that certifies the system's safety and efficacy for use in anatomic and reverse shoulder surgeries.

Comprehensive Shoulder Care Solution

The AETOS Shoulder System is designed to offer surgeons an all-encompassing toolkit for both anatomic and reverse shoulder replacement procedures. Its compatibility with sophisticated preoperative planning software, ATLASPLAN◊, and the use of custom-tailored instrumentation heralds a significant leap forward in personalized patient care. These features allow for a highly accurate approach to surgery, potentially reducing operating times and enhancing clinical outcomes.

Impact on the Market and Investors

Following the announcement, Smith+Nephew's stock tickers, LSE:SN and NYSE:SNN, may catch the attention of investors tracking advancements in medical technology and personalized healthcare solutions. With the commercialization of the AETOS Shoulder System and its acclaimed regulatory clearance, Smith+Nephew further cements their reputation as innovators in the orthopedic space.

Smith+Nephew, AETOS, Shoulder, System, Technology, Medical, AAOS, Launch, Investment, Clearance, Innovation, Orthopedic